Immediately following the 2024 presidential election, GOP leaders in the House of Representatives, Senate, and incoming administration expressed a desire to use a procedural tool to advance partisan spending legislation.
AMCP and its members advocate for bipartisan legislation that eliminates bureaucratic barriers to high-quality, innovative therapies, while lowering the bill footed by patients, families, government, employers, and other healthcare payers.
With Vice President Kamala Harris likely to receive the Democratic nomination, we outline the health policy positions she has supported as a Senator, Vice President, and in her 2020 presidential campaign.
Host Fred Goldstein invites Jennifer Mathieu, Senior Vice President, Professional & Government Affairs to discuss the Prescription Digital Therapeutics Act, the Medicaid MVPs for Patient Act and other AMCP legislative priorities.
Host Fred Goldstein invites Adam Colborn, Director, Government Affairs at AMCP to discuss AMCP Federal Legislative Priorities on this second episode of a two part discussion.
Health care expert Fred Goldstein sits down with Adam Colborn, director of government affairs at AMCP, to discuss AMCP’s federal policy priorities in the 118th Congress.
AMCP welcomes the introduction of the Medicaid VBPs for Patients Act. The legislation would expand Medicaid access to novel therapies.
AMCP webinar that discussed AMCP's latest federal and state legislative and regulatory actions.
AMCP webinar that discussed AMCP's latest federal and state legislative and regulatory actions.
AMCP webinar that discussed AMCP's latest federal and state legislative and regulatory actions.
AMCP webinar that discussed AMCP's latest federal and state legislative and regulatory actions.
AMCP webinar that discussed AMCP's latest federal and state legislative and regulatory actions.
